지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2011.6
- 수록면
- 11 - 22 (12page)
이용수
초록· 키워드
오류제보하기
Neuropathy in cancer patients or patients with peripheral neuropathy is a common and often difficult and debilitating complication of cancer or the treatment-related. Chemotherapy-Induced Peripheral Neuropathy (CIPN) is most widely reported and has been the focus of research efforts among the various types of neuropathies in cancer patients. Platinum-based drugs, such as cisplatin and oxaliplatin, are well-known for inducing chronic sensory neuropathies, but their acute and motor neurotoxicities are less well characterized.
Multidisciplinary team was charged with the review the literature and discussion intervention strategies currently available to patients as well as areas that require research efforts for the possible prevention, diagnosis, and management of peripheral neuropathy.
Effective management of neuropathy or CIPN depends on early diagnosis and an understanding of its underlying causes in the individual patient. Patients with neuropathic pain (NP) are also challenging to manage and evidencebased clinical recommendations for pharmacologic management are needed.
The objectives of this article are to discuss: Systematic literature reviews, randomized clinical trials, and existing guidelines were evaluated in prevention, assessment and treatment of the various types of neuropathies in cancer patients
Multidisciplinary team was charged with the review the literature and discussion intervention strategies currently available to patients as well as areas that require research efforts for the possible prevention, diagnosis, and management of peripheral neuropathy.
Effective management of neuropathy or CIPN depends on early diagnosis and an understanding of its underlying causes in the individual patient. Patients with neuropathic pain (NP) are also challenging to manage and evidencebased clinical recommendations for pharmacologic management are needed.
The objectives of this article are to discuss: Systematic literature reviews, randomized clinical trials, and existing guidelines were evaluated in prevention, assessment and treatment of the various types of neuropathies in cancer patients
목차
서론
본론
결론
REFERENCES
Abstract
참고문헌 (0)
참고문헌 신청이 논문의 저자 정보
이 논문과 함께 이용한 논문
다발성 골수종 환자의 삶의 질
조관숙
,
반자영
,
윤지연
외 3명
성인간호학회지
2016
.06
항암화학요법을 받는 암환자의 말초신경병증과 우울
김경연
,
이승희
,
오복자
Asian Oncology Nursing
2015
.09
Relationship between Chemotherapy-induced Peripheral Neuropathy and Quality of Life in Patients with Hematologic Malignancies
Song
,
Chi Eun
,
Kim
외 3명
성인간호학회지
2015
.06
다발성 골수종 환자의 삶의 질 영향요인
김혜숙
,
이명선
Asian Oncology Nursing
2015
.03
암환자의 항암화학요법으로 인한 말초신경병성 증상과 통증
차경숙
,
조옥희
성인간호학회 학술대회
2013
.12
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2014-513-001297006